About Treos Bio
Treos Bio is a company based in London (United Kingdom) founded in 2013.. Treos Bio has raised $22 million across 2 funding rounds from investors including Luminous Ventures and Isabel Fox. The company has 12 employees as of December 31, 2020. Treos Bio offers products and services including PolyPEPI1018 and PEPI Technology. Treos Bio operates in a competitive market with competitors including Guardant Health, MedGenome, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter London, United Kingdom
- Employees 12 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Treos Bio Limited
- Date of Incorporation 20 Oct, 2016
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
$-7.06 M (USD)19as on Dec 31, 2018
-
EBITDA
$-7.05 M (USD)19as on Dec 31, 2018
-
Total Equity Funding
$22 M (USD)
in 2 rounds
-
Latest Funding Round
$14 M (USD), Series B
Mar 31, 2021
-
Investors
Luminous Ventures
& 1 more
-
Employee Count
12
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Treos Bio
Treos Bio offers a comprehensive portfolio of products and services, including PolyPEPI1018 and PEPI Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccine for colorectal cancer inducing strong immune responses.
Platform for developing effective peptide-based cancer treatments.
Unlock access to complete
Unlock access to complete
Funding Insights of Treos Bio
Treos Bio has successfully raised a total of $22M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $14 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $14.0M
-
First Round
First Round
(13 Feb 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series B - Treos Bio | Valuation | Luminous Ventures | |
| Feb, 2017 | Amount | Series A - Treos Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Treos Bio
Treos Bio has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Luminous Ventures and Isabel Fox. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by Luminous Ventures venture capital firm.
|
Founded Year | Domain | Location | |
|
IF
Isabel Fox |
Angel investor focusing on Indian startups, with a background in tech and innovation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Treos Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Treos Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Treos Bio Comparisons
Competitors of Treos Bio
Treos Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, MedGenome, Foundation Medicine, ArcherDX and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Treos Bio
Frequently Asked Questions about Treos Bio
When was Treos Bio founded?
Treos Bio was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Treos Bio located?
Treos Bio is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Treos Bio a funded company?
Treos Bio is a funded company, having raised a total of $22M across 2 funding rounds to date. The company's 1st funding round was a Series A of $8M, raised on Feb 13, 2017.
How many employees does Treos Bio have?
As of Dec 31, 2020, the latest employee count at Treos Bio is 12.
What does Treos Bio do?
Developer of cancer vaccines and companion diagnostics. Its platform technology uses proprietary algorithms to mine patient genetic profiles and match them to their response to therapeutic vaccines. It has two diagnostic products. The PEPI test is a genetic test that predicts the patients antigen-specific immune response, which in turn can be used to predict the patients response to therapeutic cancer vaccines. The PEPI test is approved as an IVD kit in Europe. The other diagnostic test under development is the Melanoma PEPI Test for identifying high-risk melanoma patients. In addition, the company is developing the PolyPEPI vaccine and companion diagnostic family of products for melanoma, breast cancer, and lung cancer. The companion diagnostics will be used for the biomarker-based stratification of patients.
Who are the top competitors of Treos Bio?
Treos Bio's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Treos Bio offer?
Treos Bio offers PolyPEPI1018 and PEPI Technology.
Who are Treos Bio's investors?
Treos Bio has 2 investors. Key investors include Luminous Ventures, and Isabel Fox.